Literature DB >> 22989484

1,25-Dihydroxyvitamin D3 and the aging-related forkhead box O and sestrin proteins in osteoblasts.

Guy Eelen1, Lieve Verlinden, Mark B Meyer, Rik Gijsbers, J Wesley Pike, Roger Bouillon, Annemieke Verstuyf.   

Abstract

Forkhead Box O (FoxO) transcription factors and Sestrins (SESN) are highly conserved and related stress-responsive proteins that protect the organism against age-related pathologies. For FoxOs, growing evidence shows a crucial role in osteoblast function. Here we investigated the role of different FoxO and SESN isoforms in 1,25(OH)2D3-treated MC3T3-E1 osteoblasts. 1,25(OH)2D3 rapidly and strongly induced the expression of SESN1 and FoxO3a but down-regulated the expression of SESN3 and FoxO1. SESN2 and FoxO4 levels were hardly affected by 1,25(OH)2D3. Chromatin Immunoprecipitation (ChIP)-sequencing revealed significant VDR/RXR binding to a DR3-type VDRE in SESN1 but not in the genomic region where FoxO3a is located. Mutation of the SESN1 VDRE abolished responsiveness to 1,25(OH)2D3 in luciferase-based transfection assays. siRNA-mediated knock-down of SESN1, SESN3, FoxO1 or FoxO3a did not prevent 1,25(OH)2D3 from reducing the expression of cell cycle markers like Cyclin D1 and Cdc6 and from exerting its characteristic antiproliferative effect on MC3T3-E1 osteoblasts. Accordingly, the 1,25(OH)2D3-induced reduction in the number of S-phase cells was also maintained. The antiproliferative effect was still present in primary osteoblast in which all three FoxO isoforms were deleted (TKOpOB). Interestingly, both MC3T3-E1 osteoblasts in which FoxO1 was knocked-down and TKOpOBs accumulated significantly more reactive oxygen species (ROS) after treatment with 1,25(OH)2D3 than control cells. siRNA-mediated knock-down of individual SESN isoforms did not result in significant differences in ROS levels. In conclusion, 1,25(OH)2D3 directly and indirectly alters the expression levels of different FoxO and SESN isoforms in osteoblasts, presumably not to exert its antiproliferative action but to control ROS levels. This article is part of a Special Issue entitled 'Vitamin D Workshop'.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22989484     DOI: 10.1016/j.jsbmb.2012.09.011

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  12 in total

Review 1.  FoxO3a and disease progression.

Authors:  Richard Seonghun Nho; Polla Hergert
Journal:  World J Biol Chem       Date:  2014-08-26

2.  Vitamin D endocrine system and osteoblasts.

Authors:  Marjolein van Driel; Johannes P T M van Leeuwen
Journal:  Bonekey Rep       Date:  2014-02-05

3.  FOXO1 Mediates Vitamin D Deficiency-Induced Insulin Resistance in Skeletal Muscle.

Authors:  Songcang Chen; S Armando Villalta; Devendra K Agrawal
Journal:  J Bone Miner Res       Date:  2015-11-09       Impact factor: 6.741

4.  Asiatic acid improves high-fat-diet-induced osteoporosis in mice via regulating SIRT1/FOXO1 signaling and inhibiting oxidative stress.

Authors:  Xiaosi Chen; Dengpeng Han; Tianfeng Liu; Chengshuo Huang; Zibing Hu; Xiaoyan Tan; Shaoke Wu
Journal:  Histol Histopathol       Date:  2022-03-01       Impact factor: 2.130

Review 5.  Vitamin D in physiological and pathological aging: Lesson from centenarians.

Authors:  Evelyn Ferri; Martina Casati; Matteo Cesari; Giovanni Vitale; Beatrice Arosio
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

Review 6.  Vitamin D and gene networks in human osteoblasts.

Authors:  Jeroen van de Peppel; Johannes P T M van Leeuwen
Journal:  Front Physiol       Date:  2014-04-09       Impact factor: 4.566

7.  Ascorbic Acid Attenuates Senescence of Human Osteoarthritic Osteoblasts.

Authors:  Maximilian G Burger; Amir Steinitz; Jeroen Geurts; Benjamin E Pippenger; Dirk J Schaefer; Ivan Martin; Andrea Barbero; Karoliina Pelttari
Journal:  Int J Mol Sci       Date:  2017-11-24       Impact factor: 5.923

8.  Statin and Bisphosphonate Induce Starvation in Fast-Growing Cancer Cell Lines.

Authors:  Heidrun Karlic; Florian Haider; Roman Thaler; Silvia Spitzer; Klaus Klaushofer; Franz Varga
Journal:  Int J Mol Sci       Date:  2017-09-15       Impact factor: 5.923

9.  Increased FoxO3a expression prevents osteoblast differentiation and matrix calcification.

Authors:  Kathy C Tang; Wanling Pan; Michael R Doschak; R Todd Alexander
Journal:  Bone Rep       Date:  2019-04-26

10.  Vitamin D, FOXO3a, and Sirtuin1 in Hashimoto's Thyroiditis and Differentiated Thyroid Cancer.

Authors:  Natascha Roehlen; Claudia Doering; Martin-Leo Hansmann; Frank Gruenwald; Christian Vorlaender; Wolf Otto Bechstein; Katharina Holzer; Klaus Badenhoop; Marissa Penna-Martinez
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.